Numinus Wellness, Inc. (NUMIF)
0.0216
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Numinus Wellness Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 8.032M |
| June 09, 2026 | 8.824M |
| June 08, 2026 | 8.496M |
| June 05, 2026 | 8.817M |
| June 04, 2026 | 8.785M |
| June 03, 2026 | 10.55M |
| June 02, 2026 | 8.464M |
| June 01, 2026 | 9.106M |
| May 29, 2026 | 8.561M |
| May 28, 2026 | 12.15M |
| May 27, 2026 | 10.71M |
| May 26, 2026 | 13.34M |
| May 22, 2026 | 15.81M |
| May 21, 2026 | 13.95M |
| May 20, 2026 | 12.34M |
| May 19, 2026 | 10.93M |
| May 18, 2026 | 10.74M |
| May 15, 2026 | 13.95M |
| May 14, 2026 | 13.98M |
| May 13, 2026 | 13.91M |
| May 12, 2026 | 15.52M |
| May 11, 2026 | 17.12M |
| May 08, 2026 | 17.12M |
| May 07, 2026 | 10.74M |
| May 06, 2026 | 10.93M |
| Date | Value |
|---|---|
| May 05, 2026 | 13.19M |
| May 04, 2026 | 12.41M |
| May 01, 2026 | 9.106M |
| April 30, 2026 | 7.535M |
| April 29, 2026 | 12.60M |
| April 28, 2026 | 15.52M |
| April 27, 2026 | 15.52M |
| April 24, 2026 | 15.55M |
| April 23, 2026 | 15.48M |
| April 22, 2026 | 15.52M |
| April 21, 2026 | 12.31M |
| April 20, 2026 | 10.07M |
| April 17, 2026 | 4.169M |
| April 16, 2026 | 4.297M |
| April 15, 2026 | 4.714M |
| April 14, 2026 | 3.977M |
| April 13, 2026 | 3.977M |
| April 10, 2026 | 3.977M |
| April 09, 2026 | 4.297M |
| April 08, 2026 | 4.105M |
| April 07, 2026 | 3.977M |
| April 06, 2026 | 4.634M |
| April 02, 2026 | 4.137M |
| April 01, 2026 | 4.297M |
| March 31, 2026 | 4.938M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 10.45M |
| Edesa Biotech, Inc. | 44.67M |
| CNBX Pharmaceuticals, Inc. | 1.322M |
| GB Sciences, Inc. | -- |
| ProMIS Neurosciences, Inc. | 27.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4755M |
| Revenue (Quarterly) | 1.282M |
| Total Expenses (Quarterly) | 1.758M |
| EPS Diluted (Quarterly) | -0.0017 |